Skip to content

How to get more Botox patients: a plan for injector practices

A front desk team member at a med spa and aesthetic clinic handles a new patient call

This guide is for med spas, dermatology and plastic surgery practices and their front desks: how to answer questions about Botox and other neurotoxin injections (price, what can be treated, who will inject) accurately, what the FDA labels say that affects your marketing, and how to follow up and measure toxin requests.

  1. SearchAn adult looks for care near them.
  2. Your pageWhat you treat, who sees them, one way to book.
  3. Call or formThey call or send a request.
  4. Front deskBooks the visit and never guesses a cause.
  5. Clinical teamThe clinician decides the plan.
How a new patient request reaches your practice.

1. Know which products you use, and what each is approved for

Several botulinum toxin products are FDA approved for cosmetic use, each with its own label. You can read the current labels in DailyMed or find them through Drugs@FDA. For example:

  • BOTOX Cosmetic (onabotulinumtoxinA) is indicated in adults for the temporary improvement in the appearance of moderate to severe glabellar lines, lateral canthal lines, forehead lines and platysma bands, each tied to specific muscle activity.
  • Dysport, Xeomin, Jeuveau, Daxxify and Letybo each list the cosmetic and, where relevant, medical indications in their own label; for several, the cosmetic indication is glabellar lines only. Dysport’s glabellar lines indication is for adults under 65.
  • Each label carries a boxed warning on distant spread of toxin effect, stating that the effects of all botulinum toxin products may spread from the area of injection.

For marketing, that means: name the product you actually use (do not call every neurotoxin “Botox”), describe results as temporary improvement in appearance, and know whether an area you advertise is within the product’s approved indications. The FTC’s Health Products Compliance Guidance says health-related claims must be truthful, not misleading and supported by competent and reliable scientific evidence.

2. Price per unit is not comparable across products

If a caller starts with the price per unit, keep this in mind: the BOTOX Cosmetic label states that its units of biological activity cannot be compared to nor converted into units of any other botulinum toxin product, and the other labels carry similar statements. So a low price per unit for one product does not show that a treatment is cheaper than another product at a higher price per unit.

  • Say which product a unit price applies to.
  • Explain that the provider decides the number of units after assessing the patient.
  • Give the total for the plan before treatment, in writing if the patient wants it.
  • If you price by area, say what an area includes.

Our patient guide on what happens at a Botox consultation answers the same price questions from the patient’s side.

3. Be ready for “Who will inject me?”

In 2024 FDA warned about counterfeit Botox found in multiple states. It said the incidents occurred when counterfeit Botox was injected by licensed and unlicensed individuals and/or in non-medical or unlicensed settings, that the products appear to have been purchased from unlicensed sources, and it advised patients to ask their health care professional if they are licensed and trained to administer the product.

  • Give the front desk an accurate answer about who injects and their credentials. Who may inject, and under what supervision, depends on state law; check it with counsel and your licensing boards.
  • Buy product only through the manufacturer or authorized distributors, and be ready to tell a patient where it comes from.
  • Do not compete on a price that only an unlicensed source could support.

4. Answer first-call questions without giving medical advice

  • “How much is it?” Explain how you price (per unit of a named product, or per area) and that the total is set after assessment.
  • “Can you treat [area]?” Say the provider decides at the consultation; do not promise a result.
  • “How long does it last?” Use only wording your medical director approves, and describe results as temporary.
  • “Is it safe?” Say the provider will go through benefits and risks at the consultation, and point to the product’s FDA Medication Guide.

Our new patient phone script has a call structure you can adapt.

5. Use photos and promotions carefully

  • Get written authorization before publishing before-and-after photos, and keep conditions comparable; see before-and-after photos.
  • If you sell packages or memberships, state exactly what is included and how unused visits are handled; see memberships and packages.
  • Avoid words like “painless”, “no risk” or “guaranteed”.

6. Follow up, then measure toxin requests separately

  • Answer new requests quickly; our guide on speed to lead explains why.
  • Text only with the right consent; see texting patients and the TCPA.
  • Track toxin requests, consultations and first treatments by source, and treat repeat visits as their own measure, because results are temporary and patients may return.
  • Our guide on tracking new patient sources shows how.

Where MediLeadGen fits

MediLeadGen sends practices requests from people interested in cash-pay elective treatments such as injectables. Each request goes to one practice only, with the person’s consent naming that practice, at a fixed price per delivered request.

See how it works for practices

Questions practices ask

How do we get more Botox patients?

Answer requests quickly, name the product you use, explain pricing as a total for the plan, give an accurate answer about who injects, keep claims within the FDA label and supported by evidence, follow up with consent, and track toxin requests and repeat visits separately.

Can we compare our price per unit with another clinic’s?

Only for the same product. The BOTOX Cosmetic label says its units cannot be compared to nor converted into units of any other botulinum toxin product, so unit prices across products are not like for like.

Can we call every neurotoxin treatment Botox?

Avoid it. Botox is one product; Dysport, Xeomin, Jeuveau, Daxxify and Letybo are others with their own labels. Name the product you actually use so the claim is truthful.

What did FDA say about counterfeit Botox?

In 2024 FDA warned about counterfeit Botox found in multiple states, apparently bought from unlicensed sources, and advised patients to ask whether their provider is licensed and trained to administer the product.

General information for practice teams, not legal or clinical advice. Check product labels, state scope-of-practice and supervision rules, and your advertising with counsel and your medical director. Last reviewed October 2026.

More resources

All resources for practices